These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32720296)

  • 21. [Regional initiative on health care reform in Latin America and the Caribbean].
    Crocco P; Schroeder P; Villen MT; Yen E
    Rev Panam Salud Publica; 2000; 8(1-2):135-9. PubMed ID: 11026784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Policy of Multisource Drug Products in Latin America: Opportunities and Challenges on the Application of Bioequivalence In Vitro Assays.
    Miranda-Pérez de Alejo C; Aceituno Álvarez A; Mendes Lima Santos G; Fernández Cervera M; Jung-Cook H; Cabrera-Pérez MÁ
    Ther Innov Regul Sci; 2021 Jan; 55(1):65-81. PubMed ID: 32602028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regulatory Science in Practice (Pharmaceuticals and Medical Devices Agency)].
    Hojo T
    Yakugaku Zasshi; 2017; 137(4):439-442. PubMed ID: 28381721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The European Medicines Agency facilitates access to medicines in low- and middle-income countries.
    Cavaller Bellaubi M; Harvey Allchurch M; Lagalice C; Saint-Raymond A
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):321-325. PubMed ID: 32053756
    [No Abstract]   [Full Text] [Related]  

  • 25. Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products.
    O'Dwyer L; Nolan L; Fisher C
    Biomed Hub; 2017; 2(Suppl 1):222-229. PubMed ID: 31988952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The uses of modern technologies: problems and perspectives for industrialized and developing countries.
    Banta D
    Bull Pan Am Health Organ; 1984; 18(2):139-50. PubMed ID: 6487871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovation in Chemistry, Manufacturing, and Controls-A Regulatory Perspective From Industry.
    Cauchon NS; Oghamian S; Hassanpour S; Abernathy M
    J Pharm Sci; 2019 Jul; 108(7):2207-2237. PubMed ID: 30794794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The marketing potential of corporate social responsibility activities: the case of the alcohol industry in Latin America and the Caribbean.
    Pantani D; Peltzer R; Cremonte M; Robaina K; Babor T; Pinsky I
    Addiction; 2017 Jan; 112 Suppl 1():74-80. PubMed ID: 27661467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Collaborative study on regulatory science for facilitating clinical development of gene therapy products for genetic diseases].
    Uchida E; Igarashi Y; Sato Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):10-2. PubMed ID: 25707196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Japanese Regulatory Frameworks for Clinical Research and Marketing Authorization of Gene Therapy and Cellular Therapy Products.
    Nagai S; Ozawa K
    Curr Gene Ther; 2017; 17(1):17-28. PubMed ID: 28382858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Small- and Medium-sized Enterprises Office (SME Office) at the European Medicines Agency.
    Carr M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):20-3. PubMed ID: 20101799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience.
    Toscano CM; Jauregui B; Janusz CB; Sinha A; Clark AD; Sanderson C; Resch S; Ruiz Matus C; Andrus JK;
    Vaccine; 2013 Jul; 31 Suppl 3():C12-8. PubMed ID: 23777685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Registration pathways to accelerate regulatory assessment of innovative medicines in Latin America.
    Padua A; Partika L; Bonamici D; Rahal Cabello J; Kohiyama C; Spinardi P; Castro A; Rolim A; Souto F
    J Public Health Policy; 2020 Dec; 41(4):481-495. PubMed ID: 32879437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood safety: Opportunities and challenges addressed through Critical Path research at FDA.
    Atreya CD; Epstein JS
    Drug Discov Today Technol; 2007; 4(2):51-4. PubMed ID: 24980841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolving Global Regulatory Science Through the Voluntary Submission of Data: A 2013 Assessment.
    Walker EG; Brumfield M; Compton C; Woosley R
    Ther Innov Regul Sci; 2014 Mar; 48(2):236-245. PubMed ID: 30227514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional integration and south-south cooperation in health in Latin America and the Caribbean.
    Carrillo Roa A; Santana JP
    Rev Panam Salud Publica; 2012 Nov; 32(5):368-75. PubMed ID: 23338694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers for Pharmaceutical Innovation With Focus in Cancer Drugs, the Case of Mexico.
    Duenas-Gonzalez A; Gonzalez-Fierro A
    Ther Innov Regul Sci; 2020 Mar; 54(2):342-352. PubMed ID: 32072574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI).
    Cleary J; De Lima L; Eisenchlas J; Radbruch L; Torode J; Cherny NI
    Ann Oncol; 2013 Dec; 24 Suppl 11():xi41-50. PubMed ID: 24285228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
    PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.